Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study

The authors declare no conflict of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16108. Due to the data do-not-export policy of the Department of Data Science Research at SNUH and the CDM Project Group of the Office of eHealth Research and Business at SNUBH, sharing patient-level data with outside researchers is not permitted. However, aggregated data is available and collaborations related to this study are possible. Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2024-12-06
DOI
https://doi.org/10.1111/dom.16108
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study

Jae‐Yong Chung, Seonghae Yoon, Soo Heon Kwak, Jongseok Park et al.
1 links
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
article

Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study

Jae‐Yong Chung, Seonghae Yoon, Soo Heon Kwak, Jongseok Park, Seunghwan Baek
article en

Abstract

The authors declare no conflict of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16108. Due to the data do-not-export policy of the Department of Data Science Research at SNUH and the CDM Project Group of the Office of eHealth Research and Business at SNUBH, sharing patient-level data with outside researchers is not permitted. However, aggregated data is available and collaborations related to this study are possible. Data S1. Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Diabetes Obesity and MetabolismVol. 27(3)
Seoul National University (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR)
Ministry of Food and Drug Safety
Openalex Percentile: Top 65%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study — Jae‐Yong Chung, Seonghae Yoon, et al. · Diabetes Obesity and Metabolism (2024) | TGRS Research Map | TGRS